EXV7:F:F-iShares STOXX Europe 600 Chemicals UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 128.54

Change

+2.10 (+1.66)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-7.46 (-1.28%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.20 (-0.39%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.87 (-1.51%)

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.05 (-0.35%)

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-1.32 (-1.27%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-6.25 (-2.60%)

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

-0.22 (-2.84%)

USD 43.00B
0ZC:F Zscaler Inc

+7.08 (+4.05%)

USD 37.92B
BSND:F Danone SA

+0.40 (+2.94%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing EXV7:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.98% 84% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.98% 84% B 77% C+
Trailing 12 Months  
Capital Gain 0.14% 23% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.14% 20% F 39% F
Trailing 5 Years  
Capital Gain 43.41% 52% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.41% 52% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 6.87% 57% F 57% F
Dividend Return 6.87% 55% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.62% 46% F 81% B-
Risk Adjusted Return 46.99% 49% F 62% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.